1.
Ramakrishnan L: The zebrafish guide to tuberculosis immunity and treatment. Cold Spring Harbor symposia on quantitative biology 2013, 78:179-192.
2.
Co DO, Hogan LH, Kim SI, Sandor M: Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship. Clin Immunol 2004, 113(2):130-136.
3.
Salgame P: Host innate and Th1 responses and the bacterial factors that control Mycobacterium
tuberculosis infection. Curr Opin Immunol 2005, 17(4):374-380.
4.
Ramakrishnan L: Revisiting the role of the granuloma in tuberculosis. Nature reviews Immunology 2012, 12(5):352-366.
5.
Jo EK, Yang CS, Choi CH, Harding CV: Intracellular signalling cascades regulating innate immune responses to Mycobacteria:
branching out from Toll-like receptors. Cell Microbiol 2007, 9(5):1087-1098.
6.
Tapping RI, Tobias PS: Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2
to induce signaling. J Endotoxin Res 2003, 9(4):264-268.
7.
Means TK, Jones BW, Schromm AB, Shurtleff BA, Smith JA, Keane J, Golenbock DT, Vogel
SN, Fenton MJ: Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced
macrophage responses. J Immunol 2001, 166(6):4074-4082.
8.
Quesniaux VJ, Nicolle DM, Torres D, Kremer L, Guerardel Y, Nigou J, Puzo G, Erard
F, Ryffel B: Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation
of proinflammatory cytokines by mycobacterial lipomannans. J Immunol 2004, 172(7):4425-4434.
9.
Jung SB, Yang CS, Lee JS, Shin AR, Jung SS, Son JW, Harding CV, Kim HJ, Park JK, Paik
TH et al: The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated
protein kinase pathway and release of proinflammatory cytokines through Toll-like
receptors 2 and 4 in human monocytes. Infect Immun 2006, 74(5):2686-2696.
10.
Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland
M, Norgard MV, Plevy SE, Smale ST et al: Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999, 285(5428):732-736.
11.
Noss EH, Pai RK, Sellati TJ, Radolf JD, Belisle J, Golenbock DT, Boom WH, Harding
CV: Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and
antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 2001, 167(2):910-918.
12.
Gilleron M, Quesniaux VF, Puzo G: Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis
bacillus Calmette Guerin and mycobacterium tuberculosis H37Rv and its implication
in Toll-like receptor response. J Biol Chem 2003, 278(32):29880-29889.
13.
Gilleron M, Nigou J, Nicolle D, Quesniaux V, Puzo G: The acylation state of mycobacterial lipomannans modulates innate immunity response
through toll-like receptor 2. Chem Biol 2006, 13(1):39-47.
14.
Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S: Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial
lipoproteins. J Immunol 2002, 169(1):10-14.
15.
Takeuchi O, Kawai T, Mühlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K, Akira
S: Discrimination of bacterial lipoproteins by Toll-like receptor 6. International Immunology 2001, 13(7):933-940.
16.
Marinho FAV, de Paula RR, Mendes AC, de Almeida LA, Gomes MTR, Carvalho NB, Oliveira
FS, Caliari MV, Oliveira SC: Toll-like receptor 6 senses Mycobacterium avium and is required for efficient control
of mycobacterial infection. European Journal of Immunology 2013, 43(9):2373-2385.
17.
Basu J, Shin DM, Jo EK: Mycobacterial signaling through toll-like receptors. Front Cell Infect Microbiol 2012, 2:145.
18.
Underhill DM, Ozinsky A, Smith KD, Aderem A: Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci U S A 1999, 96(25):14459-14463.
19.
Carlos D, Frantz FG, Souza-Junior DA, Jamur MC, Oliver C, Ramos SG, Quesniaux VF,
Ryffel B, Silva CL, Bozza MT et al: TLR2-dependent mast cell activation contributes to the control of Mycobacterium tuberculosis
infection. Microbes Infect 2009, 11(8-9):770-778.
20.
Reiling N, Holscher C, Fehrenbach A, Kroger S, Kirschning CJ, Goyert S, Ehlers S:
Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in
resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 2002, 169(7):3480-3484.
21.
Drennan MB, Nicolle D, Quesniaux VJ, Jacobs M, Allie N, Mpagi J, Fremond C, Wagner
H, Kirschning C, Ryffel B: Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol 2004, 164(1):49-57.
22.
McBride A, Konowich J, Salgame P: Host defense and recruitment of Foxp3(+) T regulatory cells to the lungs in chronic
Mycobacterium tuberculosis infection requires toll-like receptor 2. PLoS Pathog 2013, 9(6):e1003397.
23.
Ogus AC, Yoldas B, Ozdemir T, Uguz A, Olcen S, Keser I, Coskun M, Cilli A, Yegin O:
The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis
disease. Eur Respir J 2004, 23(2):219-223.
24.
Biswas D, Gupta SK, Sindhwani G, Patras A: TLR2 polymorphisms, Arg753Gln and Arg677Trp, are not associated with increased burden
of tuberculosis in Indian patients. BMC research notes 2009, 2:162.
25.
Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH: Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human
macrophage class II MHC antigen processing. J Immunol 2004, 173(4):2660-2668.
26.
Saraav I, Singh S, Sharma S: Outcome of Mycobacterium tuberculosis and Toll-like receptor interaction: immune response
or immune evasion? Immunol Cell Biol 2014, 92(9):741-746.
27.
Netea MG, Van der Meer JW, Kullberg BJ: Toll-like receptors as an escape mechanism from the host defense. Trends Microbiol 2004, 12(11):484-488.
28.
Noss EH, Harding CV, Boom WH: Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone
marrow macrophages. Cell Immunol 2000, 201(1):63-74.
29.
Netea MG, Sutmuller R, Hermann C, Van der Graaf CA, Van der Meer JW, van Krieken JH,
Hartung T, Adema G, Kullberg BJ: Toll-like receptor 2 suppresses immunity against Candida albicans through induction
of IL-10 and regulatory T cells. J Immunol 2004, 172(6):3712-3718.
30.
Sing A, Rost D, Tvardovskaia N, Roggenkamp A, Wiedemann A, Kirschning CJ, Aepfelbacher
M, Heesemann J: Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated
immunosuppression. J Exp Med 2002, 196(8):1017-1024.
31.
Gehring AJ, Rojas RE, Canaday DH, Lakey DL, Harding CV, Boom WH: The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated
HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2. Infect Immun 2003, 71(8):4487-4497.
32.
Alvarez GR, Zwilling BS, Lafuse WP: Mycobacterium avium inhibition of IFN-gamma signaling in mouse macrophages: Toll-like
receptor 2 stimulation increases expression of dominant-negative STAT1 beta by mRNA
stabilization. J Immunol 2003, 171(12):6766-6773.
33.
Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, Van Dyke T, Pulendran B: Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce
distinct Th responses via differential modulation of extracellular signal-regulated
kinase-mitogen-activated protein kinase and c-Fos. J Immunol 2003, 171(10):4984-4989.
34.
Lam SH, Chua HL, Gong Z, Lam TJ, Sin YM: Development and maturation of the immune system in zebrafish, Danio rerio: a gene
expression profiling, in situ hybridization and immunological study. Dev Comp Immunol 2004, 28(1):9-28.
35.
Willett CE, Cortes A, Zuasti A, Zapata AG: Early hematopoiesis and developing lymphoid organs in the zebrafish. Developmental dynamics : an official publication of the American Association of Anatomists
1999, 214(4):323-336.
36.
Swaim LE, Connolly LE, Volkman HE, Humbert O, Born DE, Ramakrishnan L: Mycobacterium marinum Infection of Adult Zebrafish Causes Caseating Granulomatous
Tuberculosis and Is Moderated by Adaptive Immunity. Infection and Immunity 2006, 74(11):6108-6117.
37.
Davis JM, Clay H, Lewis JL, Ghori N, Herbomel P, Ramakrishnan L: Real-time visualization of mycobacterium-macrophage interactions leading to initiation
of granuloma formation in zebrafish embryos. Immunity 2002, 17(6):693-702.
38.
Meijer AH: Protection and pathology in TB: learning from the zebrafish model. Semin Immunopathol 2016, 38(2):261-273.
39.
Cronan MR, Tobin DM: Fit for consumption: zebrafish as a model for tuberculosis. Disease models & mechanisms 2014, 7(7):777-784.
40.
Yang S, Marin-Juez R, Meijer AH, Spaink HP: Common and specific downstream signaling targets controlled by Tlr2 and Tlr5 innate
immune signaling in zebrafish. BMC Genomics 2015, 16:547.
41.
Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, Janeway CA, Jr.:
MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 1998, 2(2):253-258.
42.
Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G,
Brint E, Dunne A, Gray P, Harte MT et al: Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 2001, 413(6851):78-83.
43.
Bjørn E. V. Koch SY, Gerda Lamers, Jens Stougaard & Herman P. Spaink: Intestinal microbiome adjusts the innate immune setpoint during colonization through
negative regulation of MyD88. nature comunication 2018, 9(1):4099.
44.
Anders S, McCarthy DJ, Chen Y, Okoniewski M, Smyth GK, Huber W, Robinson MD: Count-based differential expression analysis of RNA sequencing data using R and Bioconductor. Nature protocols 2013, 8(9):1765-1786.
45.
Torraca V, Cui C, Boland R, Bebelman JP, van der Sar AM, Smit MJ, Siderius M, Spaink
HP, Meijer AH: The CXCR3-CXCL11 signaling axis mediates macrophage recruitment and dissemination
of mycobacterial infection. Disease models & mechanisms 2015, 8(3):253-269.
46.
Rougeot J, Torraca V, Zakrzewska A, Kanwal Z, Jansen HJ, Sommer F, Spaink HP, Meijer
AH: RNAseq Profiling of Leukocyte Populations in Zebrafish Larvae Reveals a cxcl11 Chemokine
Gene as a Marker of Macrophage Polarization During Mycobacterial Infection. Frontiers in Immunology 2019, 10.
47.
Nikitin A, Egorov S, Daraselia N, Mazo I: Pathway studio--the analysis and navigation of molecular networks. Bioinformatics 2003, 19(16):2155-2157.
48.
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich
A, Pomeroy SL, Golub TR, Lander ES et al: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide
expression profiles. Proc Natl Acad Sci U S A 2005, 102(43):15545-15550.
49.
Kotelnikova E, Yuryev A, Mazo I, Daraselia N: Computational approaches for drug repositioning and combination therapy design. J Bioinform Comput Biol 2010, 8(3):593-606.
50.
Verway M, Bouttier M, Wang TT, Carrier M, Calderon M, An BS, Devemy E, McIntosh F,
Divangahi M, Behr MA et al: Vitamin D induces interleukin-1beta expression: paracrine macrophage epithelial signaling
controls M. tuberculosis infection. PLoS Pathog 2013, 9(6):e1003407.
51.
Leisching G, Pietersen RD, Mpongoshe V, van Heerden C, van Helden P, Wiid I, Baker
B: The Host Response to a Clinical MDR Mycobacterial Strain Cultured in a Detergent-Free
Environment: A Global Transcriptomics Approach. PLoS One 2016, 11(4):e0153079.
52.
Kubler A, Larsson C, Luna B, Andrade BB, Amaral EP, Urbanowski M, Orandle M, Bock
K, Ammerman NC, Cheung LS et al: Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis. J Infect Dis 2016, 213(4):618-627.
53.
Zhang H, Sun Z, Wei W, Liu Z, Fleming J, Zhang S, Lin N, Wang M, Chen M, Xu Y et al: Identification of serum microRNA biomarkers for tuberculosis using RNA-seq. PLoS One 2014, 9(2):e88909.
54.
Mvubu NE, Pillay B, Gamieldien J, Bishai W, Pillay M: Canonical pathways, networks and transcriptional factor regulation by clinical strains
of Mycobacterium tuberculosis in pulmonary alveolar epithelial cells. Tuberculosis (Edinb) 2016, 97:73-85.
55.
Ziegler G, Freyer D, Harhausen D, Khojasteh U, Nietfeld W, Trendelenburg G: Blocking TLR2 in vivo protects against accumulation of inflammatory cells and neuronal
injury in experimental stroke. J Cereb Blood Flow Metab 2011, 31(2):757-766.
56.
Hoffmann O, Braun JS, Becker D, Halle A, Freyer D, Dagand E, Lehnardt S, Weber JR:
TLR2 mediates neuroinflammation and neuronal damage. J Immunol 2007, 178(10):6476-6481.
57.
Gu Y, Zhang Y, Bi Y, Liu J, Tan B, Gong M, Li T, Chen J: Mesenchymal stem cells suppress neuronal apoptosis and decrease IL-10 release via
the TLR2/NFkappaB pathway in rats with hypoxic-ischemic brain damage. Mol Brain 2015, 8(1):65.
58.
Kim C, Rockenstein E, Spencer B, Kim HK, Adame A, Trejo M, Stafa K, Lee HJ, Lee SJ,
Masliah E: Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating
Autophagy. Cell Rep 2015, 13(4):771-782.
59.
Moriguchi T, Hamada M, Morito N, Terunuma T, Hasegawa K, Zhang C, Yokomizo T, Esaki
R, Kuroda E, Yoh K et al: MafB is essential for renal development and F4/80 expression in macrophages. Mol Cell Biol 2006, 26(15):5715-5727.
60.
Bauquet AT, Jin H, Paterson AM, Mitsdoerffer M, Ho IC, Sharpe AH, Kuchroo VK: The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the
development of follicular T helper cells and TH-17 cells. Nat Immunol 2009, 10(2):167-175.
61.
Cao S, Liu J, Song L, Ma X: The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression
in macrophages. J Immunol 2005, 174(6):3484-3492.
62.
Aziz A, Soucie E, Sarrazin S, Sieweke MH: MafB/c-Maf deficiency enables self-renewal of differentiated functional macrophages. Science 2009, 326(5954):867-871.
63.
Smith PA: The tantalizing links between gut microbes and the brain. Nature 2015, 526(7573):312-314.
64.
Davis DJ, Bryda EC, Gillespie CH, Ericsson AC: Microbial modulation of behavior and stress responses in zebrafish larvae. Behav Brain Res 2016, 311:219-227.
65.
de Abreu MS, Giacomini A, Zanandrea R, Dos Santos BE, Genario R, de Oliveira GG, Friend
AJ, Amstislavskaya TG, Kalueff AV: Psychoneuroimmunology and immunopsychiatry of zebrafish. Psychoneuroendocrinology 2018, 92:1-12.
66.
Phelps D, Brinkman NE, Keely SP, Anneken EM, Catron TR, Betancourt D, Wood CE, Espenschied
ST, Rawls JF, Tal T: Microbial colonization is required for normal neurobehavioral development in zebrafish. Sci Rep 2017, 7(1):11244.
67.
Borrelli L, Aceto S, Agnisola C, De Paolo S, Dipineto L, Stilling RM, Dinan TG, Cryan
JF, Menna LF, Fioretti A: Probiotic modulation of the microbiota-gut-brain axis and behaviour in zebrafish. Sci Rep 2016, 6:30046.
68.
Richardson ET, Shukla S, Sweet DR, Wearsch PA, Tsichlis PN, Boom WH, Harding CV: Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in
Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses
and inhibits Th1 polarization of responding T cells. Infect Immun 2015, 83(6):2242-2254.
69.
Piermattei A, Migliara G, Di Sante G, Foti M, Hayrabedyan SB, Papagna A, Geloso MC,
Corbi M, Valentini M, Sgambato A et al: Toll-Like Receptor 2 Mediates In Vivo Pro- and Anti-inflammatory Effects of Mycobacterium
Tuberculosis and Modulates Autoimmune Encephalomyelitis. Front Immunol 2016, 7:191.
70.
Davila S, Hibberd ML, Hari Dass R, Wong HE, Sahiratmadja E, Bonnard C, Alisjahbana
B, Szeszko JS, Balabanova Y, Drobniewski F et al: Genetic association and expression studies indicate a role of toll-like receptor 8
in pulmonary tuberculosis. PLoS Genet 2008, 4(10):e1000218.
71.
Lai YF, Lin TM, Wang CH, Su PY, Wu JT, Lin MC, Eng HL: Functional polymorphisms of the TLR7 and TLR8 genes contribute to Mycobacterium tuberculosis
infection. Tuberculosis (Edinb) 2016, 98:125-131.
72.
Reeme AE, Robinson RT: Dietary Vitamin D3 Suppresses Pulmonary Immunopathology Associated with Late-Stage
Tuberculosis in C3HeB/FeJ Mice. J Immunol 2016, 196(3):1293-1304.
73.
Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K,
Meinken C et al: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311(5768):1770-1773.
74.
Haire RN, Cannon JP, O'Driscoll ML, Ostrov DA, Mueller MG, Turner PM, Litman RT, Litman
GW, Yoder JA: Genomic and functional characterization of the diverse immunoglobulin domain-containing
protein (DICP) family. Genomics 2012, 99(5):282-291.
75.
Rodriguez-Nunez I, Wcisel DJ, Litman GW, Yoder JA: Multigene families of immunoglobulin domain-containing innate immune receptors in
zebrafish: deciphering the differences. Dev Comp Immunol 2014, 46(1):24-34.
76.
Blander JM, Medzhitov R: Regulation of Phagosome Maturation by Signals from Toll-Like Receptors. Science 2004, 304(5673):1014-1018.
77.
Rahman MJ, Chuquimia OD, Petursdottir DH, Periolo N, Singh M, Fernandez C: Impact of toll-like receptor 2 deficiency on immune responses to mycobacterial antigens. Infect Immun 2011, 79(11):4649-4656.
78.
Bernut A, Herrmann JL, Kissa K, Dubremetz JF, Gaillard JL, Lutfalla G, Kremer L: Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation. Proc Natl Acad Sci U S A 2014, 111(10):E943-952.
79.
Renshaw SA, Loynes CA, Trushell DM, Elworthy S, Ingham PW, Whyte MK: A transgenic zebrafish model of neutrophilic inflammation. Blood 2006, 108(13):3976-3978.
80.
van der Sar AM, Spaink HP, Zakrzewska A, Bitter W, Meijer AH: Specificity of the zebrafish host transcriptome response to acute and chronic mycobacterial
infection and the role of innate and adaptive immune components. Molecular immunology 2009, 46(11–12):2317-2332.
81.
Benard EL, van der Sar AM, Ellett F, Lieschke GJ, Spaink HP, Meijer AH: Infection of zebrafish embryos with intracellular bacterial pathogens. Journal of visualized experiments : JoVE 2012(61):2.
82.
Stockhammer OW, Zakrzewska A, Hegedus Z, Spaink HP, Meijer AH: Transcriptome profiling and functional analyses of the zebrafish embryonic innate
immune response to Salmonella infection. J Immunol 2009, 182(9):5641-5653.
83.
Stoop EJM, Schipper T, Rosendahl Huber SK, Nezhinsky AE, Verbeek FJ, Gurcha SS, Besra
GS, Vandenbroucke-Grauls CMJE, Bitter W, van der Sar AM: Zebrafish embryo screen for mycobacterial genes involved in the initiation of granuloma
formation reveals a newly identified ESX-1 component. Disease models & mechanisms 2011, 4(4):526-536.
84.
van Soest JJ, Stockhammer OW, Ordas A, Bloemberg GV, Spaink HP, Meijer AH: Comparison of static immersion and intravenous injection systems for exposure of zebrafish
embryos to the natural pathogen Edwardsiella tarda. BMC Immunol 2011, 12:58.
85.
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the
2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408.
86.
Marin-Juez R, Jong-Raadsen S, Yang S, Spaink HP: Hyperinsulinemia induces insulin resistance and immune suppression via Ptpn6/Shp1
in zebrafish. The Journal of endocrinology 2014.
87.
Veneman W, de Sonneville J, van der Kolk KJ, Ordas A, Al-Ars Z, Meijer A, Spaink H:
Analysis of RNAseq datasets from a comparative infectious disease zebrafish model
using GeneTiles bioinformatics. Immunogenetics 2015, 67(3):135-147.
88.
Love MI, Huber W, Anders S: Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014, 15(12):550.
89.
Kotelnikova E, Shkrob MA, Pyatnitskiy MA, Ferlini A, Daraselia N: Novel approach to meta-analysis of microarray datasets reveals muscle remodeling-related
drug targets and biomarkers in Duchenne muscular dystrophy. PLoS Comput Biol 2012, 8(2):e1002365.